|
SLC16A14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.622600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.419380E-01 |
| Normal-vs-Stage2 |
2.234800E-01 |
| Normal-vs-Stage3 |
9.925400E-01 |
| Normal-vs-Stage4 |
8.669000E-01 |
| Stage1-vs-Stage2 |
8.283600E-01 |
| Stage1-vs-Stage3 |
1.849570E-01 |
| Stage1-vs-Stage4 |
4.007200E-01 |
| Stage2-vs-Stage3 |
2.700200E-01 |
| Stage2-vs-Stage4 |
3.925400E-01 |
| Stage3-vs-Stage4 |
8.795800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.630360E-01 |
| Normal-vs-AfricanAmerican |
6.025800E-01 |
| Normal-vs-Asian |
8.648800E-01 |
| Caucasian-vs-AfricanAmerican |
9.390600E-01 |
| Caucasian-vs-Asian |
2.730400E-01 |
| AfricanAmerican-vs-Asian |
5.564200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.755660E-02 |
| Normal-vs-Female |
7.372000E-01 |
| Male-vs-Female |
1.250200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.891590E-01 |
| Normal-vs-Age(41-60Yrs) |
7.095400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.237600E-02 |
| Normal-vs-Age(81-100Yrs) |
5.284400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.165400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.312600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.513400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.146200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.838200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.699400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.577700E-03 |
| Classical-VS-Follicular |
3.768000E-01 |
| Classical-VS-Other |
7.919000E-01 |
| Classical-VS-Normal |
1.819840E-01 |
| Tall-VS-Follicular |
2.604600E-03 |
| Tall-VS-Other |
2.374200E-01 |
| Tall-VS-Normal |
6.176500E-02 |
| Follicular-VS-Other |
6.134800E-01 |
| Follicular-VS-Normal |
8.765600E-02 |
| Other-VS-Normal |
8.433600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.321800E-01 |
| Normal-vs-N1 |
6.142600E-01 |
| N0-vs-N1 |
1.580430E-01 |
|
|
